Charlie Riedel/AP

4 takeaways from the MAHA commission’s report on children’s health

The MAHA commission's assessment of children's health takes aim at poor diet, environmental toxins, low physical activity levels, and overuse of medicines.

By Isabella Cueto

STAT+ | FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’

Makary told senators that staffing cuts haven't hindered the FDA's main missions.

By Lizzy Lawrence

FDA asks mRNA vaccine makers to widen age range for rare heart risk warning

FDA asks Moderna and Pfizer-BioNTech to update warning labels on Covid-19 vaccines with expanded age range of men at risk for myocarditis.

By Elizabeth Cooney

Adobe

Opinion: I’m a Republican former congressman and doctor. The new HHS placebo-controlled trial mandate is dangerous

Placebo-controlled trials for all new vaccines, even when a proven vaccine for a disease already exists, are a violation of basic medical ethics.

By Larry Bucshon

STAT+ | As Hinge Health goes public, CEO outlines goal: ‘We’re automating care itself’

Health tech companies have yet to show consistent profitability. Hinge Health CEO Dan Perez explains how his AI-enhanced physical therapy app is different.

By Mario Aguilar

Opinion: The FDA is circumventing key roles and procedures for licensure and use of Covid vaccines

Two people with limited expertise in vaccinology — Vinay Prasad and Marty Makary — are leading the FDA vaccine evaluation process.

By Kathryn M. Edwards

Adobe

Opinion: The new era of individualized medicine requires a ‘genetic surgery’ system

Baby KJ, like author Julia Vitarello’s late daughter, Mila, has received a groundbreaking genetic treatment. The FDA must catch up.

By Julia Vitarello